Victor Shi, PhD - President, Asia Pacific, QIAGEN
Dr. Victor Shi is Asia Pacific President of QIAGEN, a publicly-listed world leading provider of sample and assay technologies in the field of molecular diagnostics.
Dr. Shi heads QIAGEN's commercial operations and strategic development in Asia and manages an organization with over 500 employees in 11 subsidiaries.
has over 17 years' experience in life science business development, management and investment.
Previously held positions include Managing Partner, Aura Partners
(Shanghai and Hong Kong), Senior Vice President of Corporate Development, Bridge Pharmaceuticals
(Menlo Park, California), Managing Director of Discovery Resources Group (Palo Alto, California), Vice President of Corporate Development at Genospectra
(Fremont, California), and Director of Asia Operations at A. M. Pappas & Associates
He was also a faculty member at National University of Singapore School of Medicine and a cancer research scientist at Merck & Co.
Dr. Shi holds PhD and MS degrees from the University of Rochester, New York, and a B.S. degree from the University of Science and Technology of China.